Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Last week, four researchers from Professor Leeson’s group within the Oxford Cardiovascular Clinical Research Facility, Division of Cardiovascular Medicine, reached the final of the Young Investigator Awards at EuroPrevent 2015 in Lisbon.

Researchers from Cardiovascular Medicine reach the final of the Young Investigator Awards at Europrevent

EuroPrevent is the leading international conference on cardiovascular prevention within the European Society of Cardiology and this was a record number of investigators to have reached the finals from a single research group. Grace Yu’s work on the endothelial cell biology of offspring of hypertensive mothers was presented alongside work from (left to right in picture) Ross Upton on the application of novel echocardiographic computational shape analysis tools, Harry Boardman on the long term cardiovascular risk in mothers who suffer pregnancy complications and Wilby Williamson’s meta-analysis of physical activity for blood pressure control in young people.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Spin-out company Alethiomics launches

The enterprise will focus on developing targeted therapies for a specific family of blood cancers.

Iron integral to the development of life on Earth – and the possibility of life on other planets

A collaboration between researchers at the MRC WIMM/RDM and Department of Earth Sciences uncovers the importance of iron for the development of complex life on Earth.

Study reveals ‘stop-eating’ response to DNA damage

A new study from the Patel Group sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.